🇺🇸 FDA
Pipeline program

B10 L-BPA Injection

2024-08-015B

Phase 2 small_molecule completed

Quick answer

B10 L-BPA Injection for Meningioma is a Phase 2 program (small_molecule) at HERON THERAPEUTICS, INC. /DE/ with 1 ClinicalTrials.gov record(s).

Program details

Company
HERON THERAPEUTICS, INC. /DE/
Indication
Meningioma
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials